PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Bartenschlager, R.* ; Urban, S.* ; Protzer, U.

Towards curative therapy of chronic viral hepatitis.

Z. Gastroenterol. 57, 61-73 (2019)
DOI
Persistent infection with hepatitis viruses is a major medical burden that unfortunately is often ignored in the general public. This results in a massive under-diagnosis of these infections. According to the world health organization, the number of people dying every year from the consequence of hepatitis virus infection has surpassed the death rate caused by malaria and HIV and is equivalent to the one of tuberculosis. These numbers call for more intense efforts to devise more effective, ideally curative therapies that must become as widely accessible as they are e.g. for HIV infected individuals. A major step forward has been the development of curative antiviral therapy for chronic hepatitis C. In the case of hepatitis D virus, new drug candidates have been developed that should receive conditional approval very soon. For chronic hepatitis B, development is lagging behind but thanks to a re-emerging interest of pharmaceutical industry that was triggered by the success of hepatitis C therapy and the availability of novel infection systems, new attempts towards curative approaches for this highly prevalent infection are undertaken. Here we summarize the current status of therapy development for chronic viral hepatitis that ultimately aims at cure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
1.236
0.681
7
8
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Viral Hepatitis ; Hepatitis Virus ; Hepatitis B ; Hepatitis D ; Hepatitis C ; Curative Therapy; Chronic Delta-hepatitis; Pegylated Interferon Alpha-2a; Ns3 Protease Inhibitor; B-virus; T-cells; Hepatocellular-carcinoma; Antiviral Activity; Envelope Proteins; Immune Tolerance; Natural-history
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0044-2739
e-ISSN 1439-7803
Zeitschrift Zeitschrift für Gastroenterologie
Quellenangaben Band: 57, Heft: 1, Seiten: 61-73 Artikelnummer: , Supplement: ,
Verlag Thieme
Verlagsort Rudigerstr 14, D-70469 Stuttgart, Germany
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
DOI 10.1055/a-0824-1576
WOS ID WOS:000455675700020
Scopus ID 85059941079
Erfassungsdatum 2019-02-28
[➜Korrektur melden]